Confessions of a Serial Scroller: My Love-Hate Relationship with Online Articles

Donahue to Discuss Breakthroughs in FinTech Innovation with Industry Leaders RADNOR, PA / September 10, 2024 / BM Technologies BM Technologies, Inc. (NYSE American:BMTX), one of the largest digital banking platforms and Banking-as-a-Service (BaaS) providers, is pleased to announce that Jamie Donahue, President and CTO of BMTX will speak at two prominent fintech and financial…

Read More

Revolutionizing IoT Security: SEALSQ Introduces Scalable PKI-Based Digital Identity and Integrity Solutions

Revolutionizing IoT Security: SEALSQ Introduces Scalable PKI-Based Digital Identity and Integrity Solutions Introduction Geneva, Switzerland, Sept. 10, 2024 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced a groundbreaking solution that embeds Public Key Infrastructure…

Read More

Unlocking the Power of Accesswire: A Comprehensive Guide to Maximizing Your Online Presence

Exploring the Depths: Core Assets Corp. Provides 2024 Exploration Update Visual Results from Diamond Drill Core Revealed VANCOUVER, BC / ACCESSWIRE / September 10, 2024 / Core Assets Corp., (“Core Assets” or the “Company”) (CSE:CC)(FSE:5RJ)(OTCQB:CCOOF) is pleased to provide an update for the 2024 exploration season that includes visual results from diamond drill core collected…

Read More

Nickel 28 Unveils Share Buyback Plans Through Normal Course Issuer Bid

Nickel 28 Capital Corp. Announces Share Buyback Toronto, Ontario–(Newsfile Corp. – September 10, 2024) – Nickel 28 Capital Corp. (TSXV: NKL) (FSE: 3JC0), also known as Nickel 28, has recently announced the purchase of 129,500 common shares through its TSX Venture Exchange approved normal course issuer bid (NCIB). The total aggregate consideration for these shares…

Read More

Corvus Pharmaceuticals Launches Phase 3 Clinical Trial for Soquelitinib: A Promising Treatment for Relapsed/Refractory Peripheral T-Cell Lymphoma Patients

Corvus Pharmaceuticals Initiates Phase 3 Trial for Soquelitinib in PTCL Background Soquelitinib is a potential first-in-class ITK inhibitor with broad potential in cancer and immune diseases. There are currently no fully approved agents for the treatment of relapsed PTCL, and soquelitinib has been granted Orphan Drug Designation and Fast Track Designation by the FDA. This…

Read More

Revolutionizing Custom Apparel: How Custom Ink Utilizes Kornit Digital’s On-Demand Technology for Fast, Accurate, and Premium Quality Results

Kornit Digital Partners with Custom Ink to Enhance Production Capabilities LAS VEGAS, Sept. 10, 2024 (GLOBE NEWSWIRE) — PRINTING UNITED EXPO 2024 Introduction Kornit Digital LTD. (NASDAQ: KRNT), a global leader in sustainable, on-demand digital fashion and textile production technologies, has partnered with Custom Ink, a prominent online provider of custom wearables and merchandise for…

Read More

PHINIA Unveils Plans for Private Offering of $400 Million Senior Notes Due 2032: A Significant Step Towards Future Growth and Success

AUBURN HILLS, Mich.–(BUSINESS WIRE)–PHINIA Inc. (“PHINIA,” “we,” “our” or the “Company”) (NYSE: PHIN) announced today that it is planning, subject to market and other customary conditions, to offer (the “Offering”) $400 million aggregate principal amount of its unsecured senior notes due 2032 (the “notes”) in a private offering that is exempt from the registration requirements…

Read More